Table of Content

1 INTRODUCTION
1.1 Study Assumptions and market definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter’s Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Source
5.1.1 Microbial
5.1.2 Plant
5.2 By Type
5.2.1 Amylase
5.2.2 Alphalase
5.2.3 Protease
5.2.4 Other Types
5.3 By Form
5.3.1 Liquid
5.3.2 Dry
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 Spain
5.4.2.2 United Kingdom
5.4.2.3 Germany
5.4.2.4 France
5.4.2.5 Italy
5.4.2.6 Russia
5.4.2.7 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle-East
5.4.5.1 South Africa
5.4.5.2 United Arab Emirates
5.4.5.3 Rest of Middle-East


6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Position Analysis
6.4 Company Profiles
6.4.1 Amano Enzyme Inc.
6.4.2 Associated British Foods PLC
6.4.3 DuPont de Nemours Inc.
6.4.4 Koninklijke DSM NV
6.4.5 A Group Soufflet company
6.4.6 CBS Brewing
6.4.7 Megazyme Ltd
6.4.8 Novozymes AS
6.4.9 Caldic BV
6.4.10 Souflett biotechnology by souflett groups


7 MARKET OPPORTUNITIES AND FUTURE TRENDS


8 IMPACT OF COVID-19 ON THE MARKET